Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Idris, NS, Grobbee, DE, Burgner, D, Cheung, MMH, Kurniati, N, Uiterwaal, CSPM.
Effects of paediatric HIV infection on childhood vasculature..
Eur Heart J
37(48)
:
3610 -3616
2016
view publication
Phuong, LK, Bonetto, C, Buttery, J, Pernus, YB, Chandler, R, Goldenthal, KL, Kucuku, M, Monaco, G, Pahud, B, Shulman, ST, et al.
Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis..
Vaccine
34(51)
:
6582 -6596
2016
view publication
Felicetti, P, Trotta, F, Bonetto, C, Santuccio, C, Brauchli Pernus, Y, Burgner, D, Chandler, R, Girolomoni, G, Hadden, RDM, Kochhar, S, et al.
Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases..
Vaccine
34(51)
:
6634 -6640
2016
view publication
Shimizu, C, Eleftherohorinou, H, Wright, VJ, Kim, J, Alphonse, MP, Perry, JC, Cimaz, R, Burgner, D, Dahdah, N, Hoang, LT, et al.
Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities..
Circ Cardiovasc Genet
9(6)
:
559 -568
2016
view publication
Qanitha, A, de Mol, BA, Pabittei, DR, Mappangara, I, van der Graaf, Y, Dalmeijer, GW, Burgner, DP, Uiterwaal, CS.
Infections in early life and premature acute coronary syndrome: A case-control study..
Eur J Prev Cardiol
23(15)
:
1640 -1648
2016
view publication